Shanghai Shyndec Pharmaceutical Co Ltd (600420) — Strategic Asset Allocation Index
Shanghai Shyndec Pharmaceutical Co Ltd (600420) has a Strategic Asset Allocation Index of 43.5% as of June 2023. Strategic assets (PP&E of CN¥6.08 Billion plus long-term investments of CN¥-) total CN¥6.08 Billion, measured against net assets of CN¥13.98 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Shanghai Shyndec Pharmaceutical Co Ltd Strategic Asset Allocation Index (2001–2021)
This chart shows how Shanghai Shyndec Pharmaceutical Co Ltd's Strategic Asset Allocation Index has evolved across 21 annual periods from 2001 to 2021. As of June 2023, the index stands at 43.5%, representing strategic assets of CN¥6.08 Billion against net assets of CN¥13.98 Billion CNY. Explore cash flow conversion of Shanghai Shyndec Pharmaceutical Co Ltd to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Shanghai Shyndec Pharmaceutical Co Ltd (2001–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Shanghai Shyndec Pharmaceutical Co Ltd from 2001 to 2021, covering 21 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see 600420 company net worth.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 62.8% | CN¥6.51 Billion | CN¥6.51 Billion | CN¥- | CN¥10.37 Billion | ▼ -2.5 pp |
| 2020 | 65.3% | CN¥6.41 Billion | CN¥6.41 Billion | CN¥- | CN¥9.82 Billion | ▼ -2.6 pp |
| 2019 | 67.9% | CN¥6.25 Billion | CN¥6.25 Billion | CN¥- | CN¥9.20 Billion | ▼ -6.8 pp |
| 2018 | 74.7% | CN¥6.31 Billion | CN¥6.10 Billion | CN¥211.63 Million | CN¥8.44 Billion | ▼ -14.8 pp |
| 2017 | 89.5% | CN¥6.85 Billion | CN¥6.74 Billion | CN¥102.01 Million | CN¥7.65 Billion | ▼ -16.3 pp |
| 2016 | 105.8% | CN¥7.34 Billion | CN¥7.25 Billion | CN¥95.86 Million | CN¥6.94 Billion | ▼ -336.3 pp |
| 2015 | 442.2% | CN¥7.13 Billion | CN¥7.05 Billion | CN¥76.17 Million | CN¥1.61 Billion | ▲ +310.6 pp |
| 2014 | 131.6% | CN¥1.83 Billion | CN¥1.83 Billion | CN¥- | CN¥1.39 Billion | ▲ +6.4 pp |
| 2013 | 125.2% | CN¥1.66 Billion | CN¥1.66 Billion | CN¥- | CN¥1.33 Billion | ▲ +30.3 pp |
| 2012 | 94.9% | CN¥1.13 Billion | CN¥1.13 Billion | CN¥- | CN¥1.19 Billion | ▲ +40.5 pp |
| 2011 | 54.3% | CN¥514.82 Million | CN¥514.82 Million | CN¥- | CN¥947.63 Million | ▲ +3.0 pp |
| 2010 | 51.4% | CN¥430.25 Million | CN¥430.25 Million | CN¥- | CN¥837.59 Million | ▲ +7.3 pp |
| 2009 | 44.1% | CN¥314.29 Million | CN¥314.29 Million | CN¥- | CN¥713.46 Million | ▲ +5.4 pp |
| 2008 | 38.6% | CN¥243.92 Million | CN¥243.92 Million | CN¥- | CN¥631.47 Million | ▼ -3.5 pp |
| 2007 | 42.1% | CN¥250.18 Million | CN¥250.18 Million | CN¥- | CN¥594.29 Million | ▼ -2.4 pp |
| 2006 | 44.5% | CN¥227.50 Million | CN¥227.50 Million | CN¥- | CN¥511.49 Million | ▲ +2.0 pp |
| 2005 | 42.5% | CN¥203.28 Million | CN¥203.28 Million | CN¥- | CN¥478.84 Million | ▲ +20.0 pp |
| 2004 | 22.4% | CN¥99.18 Million | CN¥99.18 Million | CN¥- | CN¥441.88 Million | ▼ -27.7 pp |
| 2003 | 50.1% | CN¥71.65 Million | CN¥71.65 Million | CN¥- | CN¥143.00 Million | ▼ -5.4 pp |
| 2002 | 55.5% | CN¥63.68 Million | CN¥63.68 Million | CN¥- | CN¥114.68 Million | ▲ +1.7 pp |
| 2001 | 53.8% | CN¥51.18 Million | CN¥51.18 Million | CN¥- | CN¥95.12 Million | — |